Noninvasive optoacoustic microangiography reveals dose and size dependency of radiation-induced deep tumor vasculature remodeling.
Microvascular remodeling
Optoacoustic angiography
Radiation therapy
Size-dependent vascular response
Tumor models
Journal
Neoplasia (New York, N.Y.)
ISSN: 1476-5586
Titre abrégé: Neoplasia
Pays: United States
ID NLM: 100886622
Informations de publication
Date de publication:
04 2022
04 2022
Historique:
received:
08
12
2021
revised:
04
02
2022
accepted:
11
02
2022
pubmed:
28
2
2022
medline:
7
4
2022
entrez:
27
2
2022
Statut:
ppublish
Résumé
Tumor microvascular responses may provide a sensitive readout indicative of radiation therapy efficacy, its time course and dose dependencies. However, direct high-resolution observation and longitudinal monitoring of large-scale microvascular remodeling in deep tissues remained challenging with the conventional microscopy approaches. We report on a non-invasive longitudinal study of morphological and functional neovascular responses by means of scanning optoacoustic (ОА) microangiography. In vivo imaging of CT26 tumor response to a single irradiation at varying dose (6, 12, and 18 Gy) has been performed over ten days following treatment. Tumor oxygenation levels were further estimated using diffuse optical spectroscopy (DOS) with a contact fiber probe. OA revealed the formation of extended vascular structures on the whole tumor scale during its proliferation, whereas only short fragmented vascular regions were identified following irradiation. On the first day post treatment, a decrease in the density of small (capillary-sized) and medium-sized vessels was revealed, accompanied by an increase in their fragmentation. Larger vessels exhibited an increase in their density accompanied by a decline in the number of vascular segments. Short-lasting response has been observed after 6 and 12 Gy irradiations, whereas 18 Gy treatment resulted in prolonged responses, up to the tenth day after irradiation. DOS measurements further revealed a delayed increase of tumor oxygenation levels for 18 Gy irradiations, commencing on the sixth day post treatment. The ameliorated oxygenation is attributed to diminished oxygen consumption by inhibited tumor cells but not to the elevation of oxygen supply. This work is the first to demonstrate the differential (size-dependent) nature of vascular responses to radiation treatments at varying doses in vivo. The OA approach thus facilitates the study of radiation-induced vascular changes in an unperturbed in vivo environment while enabling deep tissue high-resolution observations at the whole tumor scale.
Identifiants
pubmed: 35220045
pii: S1476-5586(22)00007-0
doi: 10.1016/j.neo.2022.100778
pmc: PMC8889238
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
100778Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors have declared that no competing interest exists
Références
Photoacoustics. 2018 Nov 23;13:25-32
pubmed: 30555784
Cancers (Basel). 2020 Jan 02;12(1):
pubmed: 31906502
Clin Cancer Res. 2003 Jun;9(6):1957-71
pubmed: 12796357
Nat Biomed Eng. 2020 Mar;4(3):286-297
pubmed: 32165736
Clin Cancer Res. 2019 Dec 15;25(24):7436-7447
pubmed: 31551349
Biomed Opt Express. 2016 Sep 12;7(10):3951-3957
pubmed: 27867706
J Photochem Photobiol B. 2016 Jul;160:72-8
pubmed: 27101274
Theranostics. 2018 Jan 1;8(1):156-168
pubmed: 29290799
Radiother Oncol. 2008 Mar;86(3):354-60
pubmed: 18077029
Cancer Growth Metastasis. 2018 Mar 09;11:1179064418761639
pubmed: 29551910
Radiat Res. 1998 Nov;150(5):549-56
pubmed: 9806597
J Biomed Opt. 2018 May;23(9):1-5
pubmed: 29790319
Radiat Res. 2000 Apr;153(4):398-404
pubmed: 10760999
J Biomed Opt. 2009 Sep-Oct;14(5):054051
pubmed: 19895152
PLoS One. 2012;7(8):e42133
pubmed: 22927920
Sci Rep. 2018 Jan 8;8(1):38
pubmed: 29311686
Radiat Res. 2015 Jun;183(6):713-21
pubmed: 26010711
Cancer Res. 1992 Sep 1;52(17):4620-7
pubmed: 1511430
Biomed Opt Express. 2020 Feb 20;11(3):1477-1488
pubmed: 32206423
Photoacoustics. 2019 Aug 12;15:100143
pubmed: 31463195
J Biomed Opt. 2018 Aug;23(8):1-14
pubmed: 30152204
Radiat Res. 2001 Feb;155(2):360-8
pubmed: 11175672
Opt Lett. 2016 Mar 1;41(5):1006-9
pubmed: 26974102
Hypoxia (Auckl). 2017 Apr 11;5:21-32
pubmed: 28443291
Int J Mol Imaging. 2013;2013:983534
pubmed: 23936648
Ultrasonography. 2017 Apr;36(2):111-119
pubmed: 28219004
Bone. 2020 Apr;133:115251
pubmed: 31978616
J Biomed Opt. 2011 Jan-Feb;16(1):011008
pubmed: 21280895
Int J Radiat Oncol Biol Phys. 2016 Apr 1;94(5):1173-80
pubmed: 26907918
Oncotarget. 2017 Jun 6;8(23):37464-37477
pubmed: 28415581
Cancer Inform. 2014 Dec 09;13(Suppl 4):65-72
pubmed: 25574127
Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):924-5
pubmed: 24969800
Photoacoustics. 2020 Jul 25;20:100201
pubmed: 32775198
Front Immunol. 2019 Jan 14;9:3107
pubmed: 30692993
Ultrasound Med Biol. 2012 Oct;38(10):1833-8
pubmed: 22766121
Radiat Res. 2012 Mar;177(3):311-27
pubmed: 22229487
Opt Express. 2007 Nov 12;15(23):15507-16
pubmed: 19550836
Int J Radiat Oncol Biol Phys. 2021 Aug 1;110(5):1519-1529
pubmed: 33775857
Blood. 2019 Jun 20;133(25):2696-2706
pubmed: 30952674
Cancers (Basel). 2021 Sep 24;13(19):
pubmed: 34638255
Chem Soc Rev. 2017 Apr 18;46(8):2158-2198
pubmed: 28276544
Sci Rep. 2016 Feb 17;6:21237
pubmed: 26883660
Cancer Invest. 1989;7(3):287-94
pubmed: 2477120
Nat Rev Cancer. 2015 Jul;15(7):409-25
pubmed: 26105538
Biomed Phys Eng Express. 2019 Mar 12;5(3):
pubmed: 34247150
Theranostics. 2018 Mar 6;8(8):2064-2078
pubmed: 29721063
Opt Lett. 2015 Apr 1;40(7):1472-5
pubmed: 25831362
Cancer Res. 2018 Oct 15;78(20):5980-5991
pubmed: 30115696
Biomed Opt Express. 2018 May 31;9(6):2871-2886
pubmed: 30258696
Radiology. 2002 Mar;222(3):789-93
pubmed: 11867802
Methods. 2010 Jan;50(1):2-13
pubmed: 19706326
Oncogene. 2003 Sep 1;22(37):5897-906
pubmed: 12947396